Dexamethasone for Cardiac Surgery Trial

NACompletedINTERVENTIONAL
Enrollment

4,500

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

November 30, 2011

Study Completion Date

December 31, 2012

Conditions
Systemic Inflammatory Response SyndromeCardiac DiseasesPostoperative Complications
Interventions
DRUG

Dexamethasone

1 mg per kg as a single dose before initiation of cardiopulmonary bypass

Trial Locations (1)

3584CX

UMC Utrecht, Utrecht

All Listed Sponsors
lead

UMC Utrecht

OTHER

NCT00293592 - Dexamethasone for Cardiac Surgery Trial | Biotech Hunter | Biotech Hunter